Your browser doesn't support javascript.
loading
Developing vaccines against epidemic-prone emerging infectious diseases.
Bernasconi, Valentina; Kristiansen, Paul A; Whelan, Mike; Román, Raúl Gómez; Bettis, Alison; Yimer, Solomon Abebe; Gurry, Céline; Andersen, Svein R; Yeskey, Debra; Mandi, Henshaw; Kumar, Arun; Holst, Johan; Clark, Carolyn; Cramer, Jakob P; Røttingen, John-Arne; Hatchett, Richard; Saville, Melanie; Norheim, Gunnstein.
Affiliation
  • Bernasconi V; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Kristiansen PA; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Whelan M; Coalition for Epidemic Preparedness Innovation (CEPI), NW1 2BE, London, UK.
  • Román RG; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Bettis A; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Yimer SA; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Gurry C; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Andersen SR; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Yeskey D; Coalition for Epidemic Preparedness Innovation (CEPI), Washington, DC, USA.
  • Mandi H; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Kumar A; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Holst J; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Clark C; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Cramer JP; Coalition for Epidemic Preparedness Innovation (CEPI), NW1 2BE, London, UK.
  • Røttingen JA; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Hatchett R; Research Council of Norway, Lysaker, Norway.
  • Saville M; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.
  • Norheim G; Coalition for Epidemic Preparedness Innovation (CEPI), NW1 2BE, London, UK.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz ; 63(1): 65-73, 2020 Jan.
Article de En | MEDLINE | ID: mdl-31776599
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins / Maladies transmissibles émergentes / Épidémies Type d'étude: Guideline Limites: Animals / Humans Pays/Région comme sujet: Africa / Europa Langue: En Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Sujet du journal: SAUDE PUBLICA Année: 2020 Type de document: Article Pays d'affiliation: Norvège
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins / Maladies transmissibles émergentes / Épidémies Type d'étude: Guideline Limites: Animals / Humans Pays/Région comme sujet: Africa / Europa Langue: En Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Sujet du journal: SAUDE PUBLICA Année: 2020 Type de document: Article Pays d'affiliation: Norvège